Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Clicks: 124
ID: 269227
2005
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
4.2
/100
14 views
14 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
AbstractBackground. Clinicians who treat patients with Clostridium difficile–associated diarrhea (CDAD) in Quebec, Canada, have noted an apparent increase in th
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (21 words).
Try re-searching for a better abstract.
| Reference Key |
jacques2005clinicalincreasing
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Pépin, Jacques;Alary, Marie-Eve;Valiquette, Louis;Raiche, Evelyne;Ruel, Joannie;Fulop, Katalin;Godin, Dominique;Bourassa, Claude; |
| Journal | clinical infectious diseases |
| Year | 2005 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
adolescent
aged
middle aged
Child
Infant
Recurrence
preschool
risk factors
anti-bacterial agents / therapeutic use
metronidazole / therapeutic use
vancomycin / therapeutic use
enterocolitis
treatment failure
quebec
pmid:15889355
doi:10.1086/430315
jacques pepin
marie-eve alary
claude bourassa
pseudomembranous / drug therapy*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.